Research We’ve Supported

Glaucoma Research we’ve funded

Glaucoma NZ has been funding research projects and investigations into glaucoma since 2005. We provide a high quality independent assessment of research projects before funding to assure the very best use of the limited funds available for research.

Our researchers investigate the causes of glaucoma and how it can be better treated. We collaborate both locally and internationally across research areas that include gene therapy, mitochondrial research, clinical genetics and more. If you have an interest in helping Glaucoma NZ support research into glaucoma, please consider a donation.

Support Glaucoma Research

2021 – Coming soon!

As advocacy leaders for glaucoma education and treatment, we are deeply committed to supporting research with real-life impact.

By funding research today means we can work together to achieve better treatments and faster diagnosis of glaucoma tomorrow.

Support Glaucoma Research

2020 – Modelling the use of OCT to prevent rare cases of vision loss

This is one of the first population-based studies of glaucoma prevalence using modern OCT scans to determine a diagnosis of early glaucoma (when visual fields are normal) and has implications for public health planning in New Zealand.

READ MORE

2019 – Identifying important demographic parameters for at risk populations susceptible to developing an acute angle closure

Research focused on identifying important demographic parameters that might identify which groups are more susceptible to developing an acute angle closure crisis

READ MORE

2018  – ‘Artificial Intelligence and Defining Glaucoma’

In line with worldwide studies, De Souza’s research focused on training a deep learning algorithm to detect glaucoma

READ MORE

2017 – Nailfold Capillary Abnormalities in Primary Open Angle Glaucoma

This study aims to identify which nailfold capillary abnormalities occur in glaucoma and to establish whether nailfold capillaroscopy can be used to predict glaucoma severity and the risk of central vision loss.

READ MORE

2012 – Recruitment and management of glaucoma patients to assess their current disease state, monitoring and treatment, and how the detection of new patients may be improved

by University of Otago, Josh Erceg.

READ MORE

2011  – Connexin 43 changes in Open-Angle glaucoma and the role of astrocytes in glaucoma

University of Otago, Peny Lin.

READ MORE

2008 – What do people with glaucoma know about their condition?

A comparative cross-sectional incidence and prevalence survey by Dr Helen V Danesh-Meyer MD, FRANZCO, & Narme C Deva MBChB.

READ MORE

2007 – ‘Determination of the genetic basis for glaucoma in a New Zealand population’

by Dr Andrea Vincent

READ MORE

Dr Jesse Gale discusses future directions in glaucoma research and treatment

The direction that Glaucoma Research is taking in the future and exciting possibilities are discussed at the virtual GNZ Glaucoma Patient Symposium 2020

Glaucoma Research


Exploring topical anti-glaucoma medication effects on the ocular surface in the context of the current understanding of dry eye

Assessing tear film parameters, ocular surface characteristics, and dry eye symptomology in patients receiving topical anti-glaucoma medications.

READ MORE

Depression and quality of life with glaucoma

Determining the prevalence of depression and its association with visual field impairment, quality of life, objective assessment of visual function, and glaucoma severity in elderly patients with glaucoma.

READ MORE

Glaucoma and the brain: Trans-synaptic degeneration, structural change, and implications for neuroprotection

A  hypothesis suggesting that glaucoma is a neurodegenerative disease. The basis for this has been the finding of central nervous system changes in glaucoma patients on histology and neuroimaging.

READ MORE

High rate of incidental glaucoma detection in New Zealand

Investigating how glaucoma is initially detected in New Zealanders and what factors aroused disease suspicion.

READ MORE

Neuroinflammation as a target for glaucoma therapy

The pathogenesis of glaucoma is still not fully clarified but a growing body of evidence suggests that neuroinflammation and immune response are part of the sequence of pathological events leading to optic neuropathy.

READ MORE

Ocular Surface disease and quality of life in patients with glaucoma

Investigating the relationship between ocular surface disease and glaucoma-related quality of Life (QoL), glaucoma severity, and treatment in patients with open-angle glaucoma.

READ MORE

Is primary open-angle glaucoma an ocular manifestation of systemic disease?

Abnormalities in blood flow to the back of the eye and the role it plays in glaucoma.

READ MORE

Neuroprotection in glaucoma: recent and future directions

The concept of neuroprotective therapy for glaucoma is that damage to retinal ganglion cells (RGCs) may be prevented by intervening in neuronal death pathways. This review focuses on strategies for neuroprotection and summarizes preclinical studies that have investigated potential agents over the last 2 years.

READ MORE

Want to Volunteer for a Clinical Research Study?

You can find out more and register your interest in taking part in current or future research with Glaucoma NZ.

.

DONATE TODAY AND SUPPORT GLAUCOMA RESEARCH

Every donation, no matter how large or small, will help support research into new ways to diagnose, treat and prevent blindness from glaucoma.

Donate Now

Donate

Help us make a difference

Your donation will help us to save sight and continue helping people with glaucoma get access to the information and support they need.

Donate

Join Glaucoma NZ

Get the support you need

Glaucoma NZ provides free information, support materials and invites to events to help you and others live well with glaucoma.

Join Glaucoma NZ